Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6544771

Title:Retroviral gene therapy vectors and therapeutic methods based thereon
Inventors:Riviere, Isabelle; Boston, MA, USA
Cohen, Lawrence K.; Oakland, CA, USA
Guild, Brad; Concord, MA, USA
Rafield, Lori F.; San Francisco, CA, USA
Robbins, Paul; Mt. Lebanon, PA, USA
Mulligan, Richard C.; Lincoln, MA, USA
Summary:This invention describes recombinant retroviral vectors useful for nonselectively transducing cells in gene therapy, containing 5' and 3' long terminal repeats derived from a retrovirus or from a murine leukaemia virus. Further disclosed are retroviral vectors which include an insertion site for genes of interest and are capable of expressing high levels of the protein derived from the genes of interest in a wide variety of transfected cell types. Also included are retroviral vectors lacking a selectable marker, thus rendering them suitable for human gene therapy in the treatment of a variety of disease states without the co-expression of a marker product, such as an antibiotic. Applications of these retroviral vectors are provided, specifically in the use of certain packaging cell lines.
Abstract:Retroviral vectors are disclosed which include an insertion site for genes of interest and are capable of expressing high levels of the protein derived from the genes of interest in a wide variety of transfected cell types. Also disclosed are retroviral vectors lacking a selectable marker, thus rendering them suitable for human gene therapy in the treatment of a variety of disease states without the co-expression of a marker product, such as an antibiotic. These retroviral vectors are especially suited for use in certain packaging cell lines.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6544771
Application Number:US1994000252710
Date Filed:02/06/1994
Date Published:08/04/2003
Assignee:Cell Genesys, Inc., Foster City, CA, USA Whitehead Institute for Biomedical Research, Cambridge, MA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/5/2020